summari lower dcb drug coat balloon
estim due recent fda dear doctor letter recommend
physician use altern paclitaxel coat devic peripher
arteri diseas pad due signal increas mortal
assum issu reduc sale mdt inpact dcb
abl off-set half pad
devic bare metal stent net impact reduct
fiscal sale estim
respect see figur impact organ growth
neglig fiscal continu model
fiscal model organ vs
prior ep estim come fiscal
lower price target
base cy ep estim
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort reflect combin follow
acquisit cov
compani data secur llc estim reuter
total peripheralsal peripher oldww peripher vs prior vs prior peripheralsal peripher oldww peripher vs prior plc
price target
price target assum cy cash ep estim risk includ
weak key end market greater share loss model delay product launch
believ deliv averag organ growth due lull major new product launch
combin competitor headwind
found minneapolis-bas lead global medic technolog compani
focus provid therapi chronic diseas compani four primari busi cardiac
vascular restor therapi minim invas therapi diabet revenu
plc incom statementin million except per share datafisc year end etot net currenc y-i expensesresearch oper incomenet interest expens amort incom tax incom adj continu year-to-year incom year-to-year incom dilut share year-to-year compani report secur llc estim medic technolog
